Annotation Detail for PKD1L3

Basic Information
Top
| Desease Name |
|---|
| PSYCH |
| Attention deficit hyperactivity disorder and conduct disorder |
| Desease Name |
|---|
| Attention deficit hyperactivity disorder and conduct disorder |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D013752 |
Tetracycline |
Tetracycline results in increased expression of PKD1L3 mRNA | increases expression | 16917069
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
3.03 | 17522070 |
| MESH:D005234 |
Fatty Liver |
|
Tetracycline |
4.67 | 16917069 19224547 |
| MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
6.20 | 9884423 |
| MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
6.85 | 11026799 |
| MESH:D017096 |
Prion Diseases |
|
Tetracycline |
6.50 | 10903871 |
PharmGKB Accession:PA134907578
| Releated disease ID |
Related disease Name |
| PA443434 | Arthritis, Rheumatoid |
| PA447197 | Attention Deficit Disorder with Hyperactivity |
| Releated drug ID |
Related drug Name |
| PA450192 | leflunomide |